Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial

Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgaeuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Suelberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Roedel C (2021)


Publication Type: Journal article

Publication year: 2021

Journal

DOI: 10.1001/jamaoncol.2021.5445

Abstract

IMPORTANCE Total neoadjuvant therapy has been increasingly adopted for multimodal rectal cancer treatment. The optimal sequence of chemoradiotherapy (CRT) and chemotherapy needs to be established.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Fokas, E., Schlenska-Lange, A., Polat, B., Klautke, G., Grabenbauer, G.G., Fietkau, R.,... Roedel, C. (2021). Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2021.5445

MLA:

Fokas, Emmanouil, et al. "Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial." JAMA Oncology (2021).

BibTeX: Download